The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...
Hosted on MSN18h
FDA & EMA Accept Biogen's Filings for Higher Dose SMA DrugBiogen BIIB announced that the FDA and EMA have accepted its regulatory filings seeking label expansion for a higher dose of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback